Category

Advertisement

Clinical Trials

Guard Therapeutics reports Phase 2 results

September 20, 2023

Guard Therapeutics has announced top-line …

Genmab and Seagen announce trial results

September 5, 2023

Genmab and Seagen have announced …

Preliminary results from Medivir Phase 2a study

August 23, 2023

The 15th patient with advanced …

First healthy volunteers dosed in Herantis’ part 2 Phase 1a study

August 22, 2023

Herantis Pharma has announced that …

Renee-Aguiar-Lucander

Calliditas announces full results from the NefIgArd Phase 3 trial

August 15, 2023

Calliditas Therapeutics has announced publication …

Annexin reports promising study results

August 15, 2023

Annexin Pharmaceuticals has announced that …

Ultimovacs lab

Ultimovacs completes enrollment in Phase II trial

August 10, 2023

Ultimovacs has announced the completion …

Paul Chaplin

Bavarian Nordic reports positive Phase 3 results

August 8, 2023

Bavarian Nordic has announced topline …

Søren Bregenholt

Alligator announces positive second Phase 2 interim results

June 28, 2023

Alligator Bioscience has announced positive …

Paul Chaplin

Bavarian Nordic reports Phase 3 topline results

June 28, 2023

Bavarian Nordic has reported results …

Genmab and AbbVie announce positive Phase 1/2 results

June 28, 2023

The two companies have announced …

Novo Nordisk Headquarter Denmark

Novo Nordisk announces Phase 3a results

June 26, 2023

Novo Nordisk has announced data …

FluoGuide presents interim phase IIa results

June 21, 2023

FluoGuide has announced positive interim …

Ultimovacs announces encouraging OS data

June 20, 2023

Ultimovacs has announced overall survival …

Zerion Pharma’s technology published in two peer-reviewed papers

June 12, 2023

Zerion Pharma has announced the …

Carlos de Sousa

Ultimovacs provides update on Phase II NIPU trial

June 12, 2023

Ultimovacs has announced the topline …

1
2
3
···
48